Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
GLP-1s, more formally called GLP-1 receptor agonists , are a relatively new and emerging class of medications used to treat diabetes and/or obesity
Method: For intramuscular or intravenous injection
Patients with genetic markers for rapid metabolism receive modified protocols and nutritional guidance to prevent nutrient depletion
According to the National Health and Nutrition Examination Surveys (NHANES) done in 19992006, only 17% of overweight or obese individuals reported being able to maintain a weight loss of at least 10% for 1 year (1125) and, in those and other studies, more than half regained their lost weight within 5 years (11251130)
On the prior authorization form, your healthcare provider will attest that you have tried these other options already and need a more effective treatment for weight management
US$ 20.76
US$ 27.78
US$ 28.40
US$ 27.20
